{"frequencyBands":{"HP:0040280":[100,100],"HP:0040281":[80,99],"HP:0040282":[30,79],"HP:0040283":[5,29],"HP:0040284":[1,4],"HP:0040285":[0,0]},"page":{"anchorSlug":"type-a-insulin-resistance-syndrome","columns":[{"gene":"","key":"MONDO:0012520/OMIM:610549","label":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","mondoId":"MONDO:0012520","onsetQualifier":null,"recordKeys":["0eb39d038e7304a9e72d5f9e7988955acf2a689ec4dbc3aa0f6bd256ad8d6320","1f4659a8dd7783922885393eee51be5546c09ea57cf726edc6274e7a84613cbe","33898f4ecacd5a4e23cf9760aaa3c026020e2752bb9d38d6197fc4cfae8c2f6e","3bb676811ff54b47538b0da930760b131955ddbab52c9a99507aa24d7d466ea4","5184bd3e509bed1582bbe99c249f30345d1ec69af444f1ff56cc77996d617c83","5ea321711162c605312cde700a1f6ddcc8b05d436ed82085dec09726cb237738","73ae6f83e0a00790b6e3a8612be420e1c7cdf54fbf6638646331d401db6ef3bc","97a8c9af6608ec227375f212f15b78e54c2ff8498a4dd8c26ff8637e223668e4","9e5dab82b6168dc1927b1ddab4a5c3a1831e4936224aec946aea0698cad23598","e68e226961af04081fc57e618cbd943367adc5ec19474630d85927342ece52af","eef60d67d78833ee372db2921df740b8b99fea9018d1b19a191a394f3e91c693"],"recordQualifiers":{},"scopeLabel":"OMIM:610549","sourceIds":["OMIM:610549"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."},{"gene":"","key":"MONDO:0012520/ORPHA:2297","label":"Insulin-resistance syndrome type A","mondoId":"MONDO:0012520","onsetQualifier":null,"recordKeys":["029bf542b7c5b4959eb1ba75e296ffa2573b7c9a9214d5e7e599ea4de3527b65","3bfcd4463d087634f4705b8397b9551ca1fbf03d2d2c6eef5268902e925a2b2b","a35f7aad823a8c68c556943f0d47290ba9a5ae858a8c81780c0469737d72d155","c9fff97f43f6a35713b115e048e0ff6581a1d67b3eee63e65da2d2578828ea64","cd41bc8bce4bf8d3cb7176ae21ec791863565a14afb1eb0be0872fc7756835eb","eb362f28aea724ab5658deba25ee4d05c8a2f4a38072de2c7fd85f341640e416","f8a6bd3a97db1d679581a58811d26f2744d7828a4362725465d4c5b55bc7bd8d"],"recordQualifiers":{},"scopeLabel":"ORPHA:2297","sourceIds":["ORPHA:2297"],"sourceScope":"This column retains the native source entry. It is not a pooled estimate for the umbrella condition."}],"comparison":{"collapseColumnsLabel":"Show initial comparisons","defaultColumnKeys":["MONDO:0012520/OMIM:610549","MONDO:0012520/ORPHA:2297"],"expandColumnsLabel":"Compare all source entries","intro":"Compare the original source entries. Different entries may describe different patient groups.","primaryFeatureIds":[],"scopeNoteHtml":"<p>Each column keeps its native condition scope. Initial features are displayed alphabetically, not ranked by clinical importance. Counts remain separate, and an empty cell does not mean a feature cannot occur.</p>"},"coverage":{"countRecords":11,"emptyColumnKeys":[],"hpoRelease":"2026-06-23","narrativeSourceChanges":[],"records":18,"sourceGroups":{"omim":0,"orphanet":7,"published":11}},"features":[{"hpoId":"HP:0000956","label":"Acanthosis nigricans","primary":false},{"hpoId":"HP:0005616","label":"Accelerated skeletal maturation","primary":false},{"hpoId":"HP:0000141","label":"Amenorrhea","primary":false},{"hpoId":"HP:0000823","label":"Delayed puberty","primary":false},{"hpoId":"HP:0025092","label":"Epidermal acanthosis","primary":false},{"hpoId":"HP:0008283","label":"Fasting hyperinsulinemia","primary":false},{"hpoId":"HP:0002230","label":"Generalized hirsutism","primary":false},{"hpoId":"HP:0007440","label":"Generalized hyperpigmentation","primary":false},{"hpoId":"HP:0001007","label":"Hirsutism","primary":false},{"hpoId":"HP:0000962","label":"Hyperkeratosis","primary":false},{"hpoId":"HP:0025691","label":"Impaired fasting glucose","primary":false},{"hpoId":"HP:0040270","label":"Impaired glucose tolerance","primary":false},{"hpoId":"HP:0030348","label":"Increased circulating androgen concentration","primary":false},{"hpoId":"HP:0000855","label":"Insulin resistance","primary":false},{"hpoId":"HP:0000831","label":"Insulin-resistant diabetes mellitus","primary":false},{"hpoId":"HP:0000147","label":"Polycystic ovaries","primary":false},{"hpoId":"HP:0001482","label":"Subcutaneous nodule","primary":false},{"hpoId":"HP:0005978","label":"Type II diabetes mellitus","primary":false}],"ledeHtml":"A patient-friendly description is not yet available in the ingested narrative sources for this condition.","mondoId":"MONDO:0012520","records":[{"frequencyKind":"range","key":"029bf542b7c5b4959eb1ba75e296ffa2573b7c9a9214d5e7e599ea4de3527b65","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2297","disease_name":"Insulin-resistance syndrome type A","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0007440","is_excluded":false,"label":"Generalized hyperpigmentation","onset_id":null,"reference":"ORPHA:2297","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"0eb39d038e7304a9e72d5f9e7988955acf2a689ec4dbc3aa0f6bd256ad8d6320","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000855","is_excluded":false,"label":"Insulin resistance","onset_id":null,"reference":"PMID:8288049","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"1f4659a8dd7783922885393eee51be5546c09ea57cf726edc6274e7a84613cbe","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0040270","is_excluded":false,"label":"Impaired glucose tolerance","onset_id":null,"reference":"PMID:8288049;PMID:2544998","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"33898f4ecacd5a4e23cf9760aaa3c026020e2752bb9d38d6197fc4cfae8c2f6e","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0000956","is_excluded":false,"label":"Acanthosis nigricans","onset_id":null,"reference":"PMID:8288049;PMID:2544998","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"3bb676811ff54b47538b0da930760b131955ddbab52c9a99507aa24d7d466ea4","raw":{"aspect":"P","body_system":"metabolic","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"0/1","hpo_id":"HP:0025691","is_excluded":true,"label":"Impaired fasting glucose","onset_id":null,"reference":"PMID:2544998","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"3bfcd4463d087634f4705b8397b9551ca1fbf03d2d2c6eef5268902e925a2b2b","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2297","disease_name":"Insulin-resistance syndrome type A","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000962","is_excluded":false,"label":"Hyperkeratosis","onset_id":null,"reference":"ORPHA:2297","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"5184bd3e509bed1582bbe99c249f30345d1ec69af444f1ff56cc77996d617c83","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000831","is_excluded":false,"label":"Insulin-resistant diabetes mellitus","onset_id":null,"reference":"PMID:2544998","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"5ea321711162c605312cde700a1f6ddcc8b05d436ed82085dec09726cb237738","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0025092","is_excluded":false,"label":"Epidermal acanthosis","onset_id":null,"reference":"PMID:8288049","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"73ae6f83e0a00790b6e3a8612be420e1c7cdf54fbf6638646331d401db6ef3bc","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000147","is_excluded":false,"label":"Polycystic ovaries","onset_id":null,"reference":"PMID:8288049","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"97a8c9af6608ec227375f212f15b78e54c2ff8498a4dd8c26ff8637e223668e4","raw":{"aspect":"P","body_system":"genitourinary","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0000141","is_excluded":false,"label":"Amenorrhea","onset_id":null,"reference":"PMID:8288049","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"count","key":"9e5dab82b6168dc1927b1ddab4a5c3a1831e4936224aec946aea0698cad23598","raw":{"aspect":"P","body_system":"skin","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0001007","is_excluded":false,"label":"Hirsutism","onset_id":null,"reference":"PMID:8288049","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"a35f7aad823a8c68c556943f0d47290ba9a5ae858a8c81780c0469737d72d155","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:2297","disease_name":"Insulin-resistance syndrome type A","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0000823","is_excluded":false,"label":"Delayed puberty","onset_id":null,"reference":"ORPHA:2297","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"c9fff97f43f6a35713b115e048e0ff6581a1d67b3eee63e65da2d2578828ea64","raw":{"aspect":"P","body_system":"musculoskeletal","disease_id":"ORPHA:2297","disease_name":"Insulin-resistance syndrome type A","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0005616","is_excluded":false,"label":"Accelerated skeletal maturation","onset_id":null,"reference":"ORPHA:2297","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"range","key":"cd41bc8bce4bf8d3cb7176ae21ec791863565a14afb1eb0be0872fc7756835eb","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2297","disease_name":"Insulin-resistance syndrome type A","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0001482","is_excluded":false,"label":"Subcutaneous nodule","onset_id":null,"reference":"ORPHA:2297","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"e68e226961af04081fc57e618cbd943367adc5ec19474630d85927342ece52af","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"1/1","hpo_id":"HP:0030348","is_excluded":false,"label":"Increased circulating androgen concentration","onset_id":null,"reference":"PMID:8288049","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"eb362f28aea724ab5658deba25ee4d05c8a2f4a38072de2c7fd85f341640e416","raw":{"aspect":"P","body_system":"endocrine","disease_id":"ORPHA:2297","disease_name":"Insulin-resistance syndrome type A","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0005978","is_excluded":false,"label":"Type II diabetes mellitus","onset_id":null,"reference":"ORPHA:2297","source_release":"2026-06-23"},"sourceGroups":["orphanet"]},{"frequencyKind":"count","key":"eef60d67d78833ee372db2921df740b8b99fea9018d1b19a191a394f3e91c693","raw":{"aspect":"P","body_system":"endocrine","disease_id":"OMIM:610549","disease_name":"Diabetes mellitus, insulin-resistant, with acanthosis nigricans","evidence":"PCS","frequency_raw":"2/2","hpo_id":"HP:0008283","is_excluded":false,"label":"Fasting hyperinsulinemia","onset_id":null,"reference":"PMID:8288049;PMID:2544998","source_release":"2026-06-23"},"sourceGroups":["published"]},{"frequencyKind":"range","key":"f8a6bd3a97db1d679581a58811d26f2744d7828a4362725465d4c5b55bc7bd8d","raw":{"aspect":"P","body_system":"skin","disease_id":"ORPHA:2297","disease_name":"Insulin-resistance syndrome type A","evidence":"TAS","frequency_raw":"HP:0040281","hpo_id":"HP:0002230","is_excluded":false,"label":"Generalized hirsutism","onset_id":null,"reference":"ORPHA:2297","source_release":"2026-06-23"},"sourceGroups":["orphanet"]}],"referenceLabels":{},"references":{"causeHtml":"<p>No mapped MedlinePlus condition document in this snapshot.</p>","identityNote":"MONDO defines condition identity and route membership. Native evidence populations and narrative coverage retain their separate scopes.","importantHtml":""},"sections":[{"bodyHtml":"<p>No MedlinePlus narrative has been mapped to this MONDO condition. Feature annotations, when available, are retained below.</p>","key":"overview","title":"Condition overview"}],"sharedSources":[],"slug":"type-a-insulin-resistance","sourceDocuments":[],"sourceNote":"MONDO condition identity; scoped MedlinePlus enrichment where available; original HPO annotations.","takeawayHtml":"Cause information is not available in the mapped narrative sources for this condition.","title":"insulin-resistance syndrome type A"},"schemaVersion":1}